Phase I trial of ALLN 177 in healthy volunteers on a high oxalate diet.

Trial Profile

Phase I trial of ALLN 177 in healthy volunteers on a high oxalate diet.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Nov 2014

At a glance

  • Drugs ALLN 177 (Primary)
  • Indications Hyperoxaluria
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Allena Pharmaceuticals
  • Most Recent Events

    • 17 Nov 2014 According to an Allena Pharmaceuticals media release, data of this study were presented at the American Society of Nephrology (ASN) Kidney Week 2014.
    • 06 May 2014 New trial record
    • 29 Apr 2014 Results reported in an Allena Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top